Human IgE antibody |
10-3152 |
Fitzgerald |
1 mg |
EUR 262.8 |
Description: Mouse Monoclonal Human IgE antibody |
Ige Antibody Laboratories manufactures the approved by medicare ige antibody diagnoses reagents distributed by Genprice. The Approved By Medicare Ige Antibody Diagnoses reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ige antibody. Other Approved products are available in stock. Specificity: Approved Category: By Group: Medicare Ige
Human IgE Antibody |
NSJ Bioreagents |
250ug |
EUR 832.15 |
Description: This recombinant Human IgE antibody reacts to hIgE. No cross reactivity with IgG, IgM, IgD, or IgA. |
Anti-IgE antibody |
St John's Laboratory |
1 mg |
EUR 535.2 |
Description: Immunoglobulin E (IgE) is a class of antibody that has only been found in mammals. It plays an important role in allergy and defence against parasites. Although IgE is typically the least abundant isotype - blood serum IgE levels in a normal individual are only 0.05 % of the IgG concentration - it is capable of triggering the most powerful immune reactions. |
Anti-IgE antibody |
St John's Laboratory |
1 mg |
EUR 535.2 |
Description: Immunoglobulin E (IgE) is a class of antibody that has only been found in mammals. It plays an important role in allergy and defence against parasites. Although IgE is typically the least abundant isotype - blood serum IgE levels in a normal individual are only 0.05 % of the IgG concentration - it is capable of triggering the most powerful immune reactions. |
Anti-IgE antibody |
St John's Laboratory |
1 mg |
EUR 535.2 |
Description: Immunoglobulin E (IgE) is a class of antibody that has only been found in mammals. It plays an important role in allergy and defence against parasites. Although IgE is typically the least abundant isotype - blood serum IgE levels in a normal individual are only 0.05 % of the IgG concentration - it is capable of triggering the most powerful immune reactions. |
JBS True Blue |
MiTeGen |
300 µl |
EUR 16 |
Description: JBS True Blue |
anti-IgE receptor antibody/ Rat anti- IgE receptor antibody ELIS |
Lifescience Market |
96 Tests |
EUR 1063.2 |
Medicare Ige information
Human Acute Lymphoid Leukemia PB Plasma (Newly Diagnosed/Untreated) |
ABC-TC3011 |
AcceGen |
1 vial |
Ask for price |
|
Description: Acute Lymphoid Leukemia-PB-Plasma is obtained by centrifugation of Acute Lymphoid Leukemia peripheral blood. This product has a diminished number of cells. Acute Lymphoid Leukemia-Plasma are available in the newly diagnosed and relapsed/refractory stages. |
Human Acute Myeloid Leukemia Bone Marrow-CD34+ Cells (Newly Diagnosed) |
ABC-TC3021 |
AcceGen |
1 vial |
Ask for price |
|
Description: Acute Myeloid Leukemia-Bone Marrow-CD34+ cells are selected from adult Acute Myeloid Leukemia-Bone Marrow-Mononuclear Cells. The Bone Marrow-CD34+ stem/progenitor cells are positively isolated using a direct immunomagnetic CD34 MicroBead labeling system. Acute Myeloid LeukemiaCD34+ cells are available in the newly diagnosed and relapsed/refractory stages. |
Human Chronic Lymphoid Leukemia PB Plasma (Newly Diagnosed/Untreated) |
ABC-TC3350 |
AcceGen |
1 vial |
Ask for price |
|
Description: Chronic Lymphoid Leukemia-PB Plasma is obtained by centrifugation of the Chronic Lymphoid Leukemia-PB-Mononuclear Cells. Plasma has a diminished number of cells and platelets. Chronic Lymphoid Leukemia plasma is available in untreated and relapsed/refractory stages. |
Human Diffuse Large B-Cell Lymphoma PB Plasma (Newly Diagnosed/Untreated) |
ABC-TC3407 |
AcceGen |
1 vial |
Ask for price |
|
Description: Diffuse Large B-Cell Lymphoma-PB-Plasma is obtained by centrifugation of peripheral blood tissue. Diffuse Large B-Cell Lymphoma Plasma is available in the untreated and relapsed/refractory stages. |
Human Multiple Myeloma Bone Marrow Plasma (Newly Diagnosed/Untreated) |
ABC-TC3948 |
AcceGen |
1 vial |
Ask for price |
|
Description: Multiple Myeloma-Bone Marrow Plasma is obtained by centrifuging the Multiple Myeloma-bone marrow. The plasma has a diminished number of cells and platelets. Multiple Myeloma-Bone Marrow plasma is available in both the newly diagnosed and relapsed/refractory stages. |
Human Chronic Lymphoid Leukemia PB CD19+/CD5+ B Cells (Newly Diagnosed/Untreated) |
ABC-TC3346 |
AcceGen |
1 vial |
Ask for price |
|
Description: Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia peripheral blood mononuclear cells using a direct immunomagnetic CD19+ MicroBead labeling system. Available in untreated or relapsed/refractory stages.The co-expression of CD5 is typically found on cancerous Chronic Lymphoid LeukemiaCD19+ B cells. Current research is underway to identify the Chronic Lymphoid Leukemia clonal origin of Chronic Lymphoid Leukemia from this cell population. Although these cells appear mature in morphology, they are in developmental arrest. Researchers have shown that only 1% of these cells are in an active cycle. CD19+/CD5+ B cells play an important role in production of IgM autoantibodies. |
Human Mantle Cell Lymphoma Bone Marrow Plasma (Newly Diagnosed/Untreated) |
ABC-TC3887 |
AcceGen |
1 vial |
Ask for price |
|
Description: Mantle Cell Lymphoma-Plasma is obtained by centrifugation of blood tissues. Mantle Cell LymphomaPlasma is available in the untreated and relapsed/refractory stages. |
Human Multiple Myeloma Bone Marrow Mononuclear Cells (Newly Diagnosed) |
ABC-TC3945 |
AcceGen |
1 vial |
Ask for price |
|
Description: Multiple Myeloma-Bone Marrow-Mononuclear Cells are isolated by diluting Multiple Myeloma-bone marrow with phosphate-buffered saline and using gradient separation. Multiple Myeloma Bone Marrow-Mononuclear Cells products are available in both the newly diagnosed and relapsed/refractory stages. |
Human Acute Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
ABC-TC3006 |
AcceGen |
1 vial |
Ask for price |
|
Description: Acute Lymphoid Leukemia Bone Marrow plasma is obtained by centrifugation of the Acute Lymphoid Leukemia-bone marrow. This product has a diminished number of cells and platelets. Acute Lymphoid Leukemia plasma are available in the newly diagnosed and relapsed/refractory stages. |
Human Acute Myeloid Leukemia Bone Marrow CD34+ Cells (Newly Diagnosed/Untreated) |
ABC-TC3014 |
AcceGen |
1 vial |
Ask for price |
|
Description: Acute Myeloid Leukemia-Bone Marrow-CD34+ cells are selected from adult Acute Myeloid Leukemia-Bone Marrow-Mononuclear Cells. The Bone Marrow-CD34+ stem/progenitor cells are positively isolated using a direct immunomagnetic CD34 MicroBead labeling system. Acute Myeloid LeukemiaCD34+ cells are available in the newly diagnosed and relapsed/refractory stages. |
Human Acute Myeloid Leukemia Bone Marrow Mononuclear Cells (Newly Diagnosed) |
ABC-TC3016 |
AcceGen |
1 vial |
Ask for price |
|
Description: Bone Marrow is obtained from adult Acute Myeloid Leukemia patients. Bone Marrow-Mononuclear Cells are isolated by diluting the bone marrow with phosphate-buffered saline and using gradient separation techniques. After centrifugation, the Mononuclear Cells layer is collected. Mononuclear Cells can be processed further to isolate cell subpopulations. Acute Myeloid Leukemia-Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages. |
Human Acute Myeloid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
ABC-TC3019 |
AcceGen |
1 vial |
Ask for price |
|
Description: Acute Myeloid Leukemia-Bone Marrow Plasma is obtained by centrifugation of the adult Acute Myeloid LeukemiaBone Marrow. Plasma has a diminished number of cells and platelets. Acute Myeloid Leukemia plasma is available in the newly diagnosed and relapsed/refractory stages. |
Human Chronic Myeloid Leukemia Peripheral Blood Marrow (Newly Diagnosed) |
ABC-TC3365 |
AcceGen |
1 vial |
Ask for price |
|
Description: Chronic Myeloid Leukemia (Chronic Myeloid Leukemia) is often divided into three phases, based on clinical characteristics and laboratory findings. In the absence of interventions, Chronic Myeloid Leukemia typically begins in the chronic phase (85% of Chronic Myeloid Leukemia patients). Over the course of several years, the cancer progresses to an accelerated phase and ultimately to a blast crisis phase. |
Human Acute Lymphoid Leukemia Bone Marrow CD19+ B Cells (Newly Diagnosed/Untreated) |
ABC-TC3001 |
AcceGen |
1 vial |
Ask for price |
|
Description: Acute Lymphoid Leukemia-Bone Marrow-CD19+ B cells are positively isolated from adult Acute Lymphoid Leukemia-Bone MarrowMononuclear Cells, using a direct immunomagnetic CD19 MicroBead labeling system. These CD19+ B cells are are available in newly diagnosed and relapsed/refractory stages. |
Human Acute Lymphoid Leukemia Bone Marrow Mononuclear Cells (Newly Diagnosed) |
ABC-TC3003 |
AcceGen |
1 vial |
Ask for price |
|
Description: Bone Marrow is obtained from adult Acute Lymphoid Leukemia patients. Bone Marrow-Mononuclear Cells are isolated from bone marrow by diluting the whole bone marrow with phosphate buffered saline and using gradient separation techniques. Mononuclear Cells can be processed to isolate subpopulations. Acute Lymphoid Leukemia-Bone Marrow-Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages. |
Human Chronic Lymphoid Leukemia Bone Marrow Plasma (Newly Diagnosed/Untreated) |
ABC-TC3344 |
AcceGen |
1 vial |
Ask for price |
|
Description: Chronic Lymphoid Leukemia Bone Marrow-Plasma is obtained by centrifugation of the Chronic Lymphoid Leukemia bone marrow. Plasma has a diminished number of cells and platelets. Chronic Lymphoid Leukemia plasma is available in untreated and relapsed/refractory stages. |
Human Diffuse Large B-Cell Lymphoma Bone Marrow Plasma (Newly Diagnosed/Untreated) |
ABC-TC3405 |
AcceGen |
1 vial |
Ask for price |
|
Description: Diffuse Large B-Cell Lymphoma-PB-Plasma is obtained by centrifugation of peripheral blood tissue. Diffuse Large B-Cell Lymphoma Plasma is available in the untreated and relapsed/refractory stages. |